FLT3, a prognostic biomarker for acute myeloid leukemia (AML): Quantitative monitoring with a simple anti‐FLT3 interaction and flow cytometric method

BACKGROUND: Overexpression of fms‐like tyrosine kinase 3 (FLT3) protein in leukemia is highly related to poor prognosis and reduced survival rate in acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) patients. Simple but efficient quantification of FLT3 protein levels on the leukemi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ampasavate, Chadarat, Jutapakdee, Wasimon, Phongpradist, Rungsinee, Tima, Singkome, Tantiworawit, Adisak, Charoenkwan, Pimlak, Chinwong, Dujrudee, Anuchapreeda, Songyot
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6528579/
https://www.ncbi.nlm.nih.gov/pubmed/30737839
http://dx.doi.org/10.1002/jcla.22859

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6528579/
https://www.ncbi.nlm.nih.gov/pubmed/30737839
http://dx.doi.org/10.1002/jcla.22859

Ejemplares similares